General Information of DTT (ID: TT37GL6)

DTT Name Staphylococcus Leucyl-tRNA synthetase (Stap-coc leuS) DTT Info
Gene Name Stap-coc leuS

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tavaborole DM3ED1A Onychomycosis EE12.1 Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK-2251052 DMLFI7Q Urinary tract infection GC08 Phase 2 [2]
AN-2718 DM8B2WQ Fungal infection 1F29-1F2F Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site. Science. 2007 Jun 22;316(5832):1759-61.
2 Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. Antimicrob Agents Chemother. 2015 Jan;59(1):289-98.
3 Metalloid compounds as drugs. Res Pharm Sci. 2013 Jul-Sep; 8(3): 145-158.